MedPath

Azathioprine

Generic Name
Azathioprine
Brand Names
Azasan, Imuran, Jayempi
Drug Type
Small Molecule
Chemical Formula
C9H7N7O2S
CAS Number
446-86-6
Unique Ingredient Identifier
MRK240IY2L

Overview

Azathioprine is a prodrug of 6-mercaptopurine, first synthesized in 1956 by Gertrude Elion, William Lange, and George Hitchings in an attempt to produce a derivative of 6-mercaptopurine with a better therapeutic index. Azathioprine is used to treat inflammatory conditions like rheumatoid arthritis and as an immunosuppressant in the prevention of renal transplant rejection. Azathiprine was granted FDA approval on 20 March 1968.

Indication

Azathioprine is indicated to treat rheumatoid arthritis and prevent renal transplant rejection.

Associated Conditions

  • Atopic Dermatitis
  • Crohn's Disease (CD)
  • Immune Thrombocytopenia (ITP)
  • Kidney Transplant Rejection
  • Lupus Nephritis
  • Multiple Sclerosis
  • Pericarditis
  • Psoriasis
  • Rheumatoid Arthritis
  • Uveitis

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/06/29
Not Applicable
Active, not recruiting
2025/06/10
N/A
Completed
Bangladesh Medical University
2025/04/23
Phase 2
Not yet recruiting
2025/01/22
Phase 2
Completed
2024/10/21
Phase 2
Not yet recruiting
2024/06/26
Early Phase 1
Recruiting
Pak Emirates Military Hospital
2024/01/19
Phase 2
Recruiting
2023/08/01
Not Applicable
Active, not recruiting
2023/07/28
Phase 4
Recruiting
Chinese SLE Treatment And Research Group
2023/06/09
Phase 4
Completed
First Affiliated Hospital of Guangxi Medical University

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
AvKARE
42291-063
ORAL
100 mg in 1 1
4/13/2023
Ascend Laboratories, LLC
67877-492
ORAL
25 mg in 1 1
11/22/2021
Aphena Pharma Solutions - Tennessee, LLC
71610-124
ORAL
50 mg in 1 1
9/5/2018
American Health Packaging
68084-229
ORAL
50 mg in 1 1
8/28/2023
Hikma Pharmaceuticals USA Inc.
0143-9566
INTRAVENOUS
100 mg in 10 mL
5/15/2023
Salix Pharmaceuticals
65649-231
ORAL
75 mg in 1 1
12/18/2023
Amneal Pharmaceuticals NY LLC
60219-2037
ORAL
100 mg in 1 1
12/28/2023
Amneal Pharmaceuticals NY LLC
60219-2036
ORAL
75 mg in 1 1
12/28/2023
Zydus Pharmaceuticals USA Inc.
68382-119
ORAL
75 mg in 1 1
8/22/2023
REMEDYREPACK INC.
70518-3544
ORAL
50 mg in 1 1
1/15/2024

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
Authorised
6/21/2021

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
IMURAN TABLET 50 mg
SIN02082P
TABLET, FILM COATED
50 mg
6/24/1988
AZATHIOPRINE PCH TABLET 50 mg
SIN10165P
TABLET
50.0 mg
10/3/1998
AZAFRINE TABS. 50 mg
SIN11000P
TABLET
50 mg
6/29/1999

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Azathioprine Tablets
国药准字H31021423
化学药品
片剂
7/9/2024
Azathioprine Tablets
国药准字H41020362
化学药品
片剂
11/8/2019
Azathioprine Tablets
国药准字H20003841
化学药品
片剂
11/5/2024
Azathioprine Tablets
国药准字H31021422
化学药品
片剂
2/10/2020
Azathioprine Tablets
国药准字H33020153
化学药品
片剂
5/12/2020
Azathioprine Tablets
国药准字H20234428
化学药品
片剂
10/27/2023
Azathioprine Tablets
国药准字HJ20170288
化学药品
片剂
9/30/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath